These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23449188)

  • 1. Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum.
    Rynkiewicz A; Cybulska B; Banach M; Filipiak KJ; Guzik T; Idzior-Waluś B; Imiela J; Jankowski P; Kłosiewicz-Latoszek L; Limon J; Myśliwiec M; Opolski G; Steciwko A; Stępińska J; Zdrojewski T
    Pol Arch Med Wewn; 2013; 123(1-2):7-10. PubMed ID: 23449188
    [No Abstract]   [Full Text] [Related]  

  • 2. [Management of familial heterozygous hypercholesterolaemia. Position paper of the Polish Lipid Expert Forum].
    Rynkiewicz A; Cybulska B; Banach M; Filipiak KJ; Guzik T; Idzior Waluś B; Imiela J; Jankowski P; Kłosiewicz Latoszek L; Limon J; Myśliwiec M; Opolski G; Steciwko A; Stępińska J; Zdrojewski T;
    Kardiol Pol; 2013; 71(1):107-11. PubMed ID: 23348551
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum.
    Rynkiewicz A; Cybulska B; Banach M; Filipiak K; Guzik T; Idzior-Waluś B; Imiela J; Jankowski P; Kłosiewicz-Latoszek L; Limon J; Myśliwiec M; Opolski G; Steciwko A; Stępińska J; Zdrojewski T
    J Clin Lipidol; 2013; 7(3):217-21. PubMed ID: 23725921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management in familial hypercholesterolaemia in children and adolescents. Position of the Lipid Expert Forum].
    Myśliwiec M; Walczak M; Małecka-Tendera E; Dobrzańska A; Cybulska B; Filipiak KJ; Mazur A; Jarosz-Chobot P; Szadkowska A; Rynkiewicz A; Chybicka A; Socha P; Brandt A; Kubalska J; Bautembach-Minkowska J; Limon J; Zdrojewski T; Limon J; Banach M;
    Kardiol Pol; 2013; 71(10):1099-105. PubMed ID: 24197602
    [No Abstract]   [Full Text] [Related]  

  • 5. Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Hopkins PN; Toth PP; Ballantyne CM; Rader DJ;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S9-17. PubMed ID: 21600530
    [No Abstract]   [Full Text] [Related]  

  • 6. Heterozygous Familial Hypercholesterolemia.
    Onorato A; Sturm AC
    Circulation; 2016 Apr; 133(14):e587-9. PubMed ID: 27045133
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of high total cholesterol with coronary heart disease mortality differs among subject populations--familial hypercholesterolemia as a key concept.
    Okuyama H; Ichikawa Y; Sun Y; Hamazaki T; Lands WE
    World Rev Nutr Diet; 2007; 96():19-36. PubMed ID: 17167278
    [No Abstract]   [Full Text] [Related]  

  • 8. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Familial hypercholesterolemia: A largely underestimated cardiovascular risk].
    Ferrières J; Bruckert É; Béliard S; Rabès JP; Farnier M; Krempf M; Cariou B; Danchin N
    Ann Cardiol Angeiol (Paris); 2018 Feb; 67(1):1-8. PubMed ID: 28576280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of familial hypercholesterolemia in children and adolescents. Position paper of the Polish Lipid Expert Forum.
    Myśliwiec M; Walczak M; Małecka-Tendera E; Dobrzańska A; Cybulska B; Filipiak K; Mazur A; Jarosz-Chobot P; Szadkowska A; Rynkiewicz A; Chybicka A; Socha P; Brandt A; Bautembach-Minkowska J; Zdrojewski T; Limon J; Gidding SS; Banach M
    J Clin Lipidol; 2014; 8(2):173-80. PubMed ID: 24636176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral arterial disease in heterozygous familial hypercholesterolemia.
    Pereira C; Miname MH; Makdisse MR; Watanabe C; Pesaro AE; Jannes CE; Kalil Filho R; Pereira AC; Santos RD
    Atherosclerosis; 2015 Sep; 242(1):174-8. PubMed ID: 26201001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Familial hypercholesterolemia in cardiac rehabilitation: a new field of interest].
    Ambrosetti M; Malfatto G; Maria Cremona A; Arca M; Faggiano P
    Monaldi Arch Chest Dis; 2014 Jun; 82(2):87-92. PubMed ID: 25845092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Management of Heterozygous Familial Hypercholesterolemia. Proceedings of a workshop. July 20-21, 1992.
    Am J Cardiol; 1993 Sep; 72(10):1D-84D. PubMed ID: 8105672
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial.
    Raal F; Scott R; Somaratne R; Bridges I; Li G; Wasserman SM; Stein EA
    Circulation; 2012 Nov; 126(20):2408-17. PubMed ID: 23129602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and management of heterozygous familial hypercholesterolemia: summary and recommendations from an NHLBI workshop.
    Bild DE; Williams RR; Brewer HB; Herd JA; Pearson TA; Stein E
    Am J Cardiol; 1993 Sep; 72(10):1D-5D. PubMed ID: 8105671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features, diagnosis and frequency of familial hypercholesterolemia.
    Khachadurian AK
    Beitr Infusionsther; 1988; 23():26-32. PubMed ID: 2484779
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of mutations and genetherapy. Clinical genetics of familial hypercholesterolemia.
    Schuster H
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():4-5. PubMed ID: 8767443
    [No Abstract]   [Full Text] [Related]  

  • 18. Dutch Lipid Clinic Network low-density lipoprotein cholesterol criteria are associated with long-term mortality in the general population.
    Séguro F; Bongard V; Bérard E; Taraszkiewicz D; Ruidavets JB; Ferrières J
    Arch Cardiovasc Dis; 2015 Oct; 108(10):511-8. PubMed ID: 26073227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Femoral atherosclerosis in heterozygous familial hypercholesterolemia: influence of the genetic defect.
    Junyent M; Gilabert R; Zambón D; Pocoví M; Mallén M; Cofán M; Núñez I; Civeira F; Tejedor D; Ros E
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):580-6. PubMed ID: 18096825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers.
    Besseling J; Kindt I; Hof M; Kastelein JJ; Hutten BA; Hovingh GK
    Atherosclerosis; 2014 Mar; 233(1):219-23. PubMed ID: 24529147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.